Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study.

Turcano P, Mielke MM, Bower JH, Parisi JE, Cutsforth-Gregory JK, Ahlskog JE, Savica R.

Neurology. 2018 Nov 7. pii: 10.1212/WNL.0000000000006643. doi: 10.1212/WNL.0000000000006643. [Epub ahead of print]

PMID:
30404780
2.

Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study.

Savica R, Beach TG, Hentz JG, Sabbagh MN, Serrano GE, Sue LI, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Jacobson SA, Belden CM, Davis KJ, Zamrini E, Shprecher DR, Adler CH.

Acta Neurol Scand. 2018 Sep 19. doi: 10.1111/ane.13028. [Epub ahead of print]

PMID:
30229861
3.

Early ophthalmologic features of Parkinson's disease: a review of preceding clinical and diagnostic markers.

Turcano P, Chen JJ, Bureau BL, Savica R.

J Neurol. 2018 Sep 12. doi: 10.1007/s00415-018-9051-0. [Epub ahead of print] Review.

PMID:
30209648
4.

Orthostatic Hypotension as a Prodromal Marker of α-Synucleinopathies-Reply.

Savica R, Boeve BF, Mielke MM.

JAMA Neurol. 2018 Sep 1;75(9):1155. doi: 10.1001/jamaneurol.2018.2251. No abstract available.

PMID:
30105350
5.

Prevalence of Parkinson's disease across North America.

Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM; Parkinson’s Foundation P4 Group.

NPJ Parkinsons Dis. 2018 Jul 10;4:21. doi: 10.1038/s41531-018-0058-0. eCollection 2018.

6.

Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.

Nedelska Z, Senjem ML, Przybelski SA, Lesnick TG, Lowe VJ, Boeve BF, Arani A, Vemuri P, Graff-Radford J, Ferman TJ, Jones DT, Savica R, Knopman DS, Petersen RC, Jack CR, Kantarci K.

Neuroimage Clin. 2018 Jun 19;19:939-947. doi: 10.1016/j.nicl.2018.06.020. eCollection 2018.

7.

Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis.

Shprecher DR, Adler CH, Zhang N, Hentz JG, Serrano GE, Dugger BN, Shill HA, Savica R, Caviness JN, Sabbagh MN, Belden CM, Driver-Dunckley E, Mehta SH, Sue LI, Davis KJ, Zamrini E, Beach TG.

Parkinsonism Relat Disord. 2018 Oct;55:92-96. doi: 10.1016/j.parkreldis.2018.05.020. Epub 2018 May 17.

PMID:
29779682
8.

Molecular neuroimaging in primary progressive aphasia with predominant agraphia.

Utianski RL, Duffy JR, Savica R, Whitwell JL, Machulda MM, Josephs KA.

Neurocase. 2018 Apr;24(2):121-123. doi: 10.1080/13554794.2018.1454963. Epub 2018 Mar 23.

9.

Clinicopathological and 123I-FP-CIT SPECT correlations in patients with dementia.

Jung Y, Jordan LG 3rd, Lowe VJ, Kantarci K, Parisi JE, Dickson DW, Murray ME, Reichard RR, Ferman TJ, Jones DT, Graff-Radford J, Savica R, Machulda MM, Fields JA, Allen LA, Drubach DA, St Louis EK, Silber MH, Jack CR Jr, Knopman DS, Petersen RC, Boeve BF.

Ann Clin Transl Neurol. 2018 Jan 24;5(3):376-381. doi: 10.1002/acn3.521. eCollection 2018 Mar.

10.

When Do α-Synucleinopathies Start? An Epidemiological Timeline: A Review.

Savica R, Bradley BF, Mielke MM.

JAMA Neurol. 2018 Apr 1;75(4):503-509. doi: 10.1001/jamaneurol.2017.4243.

PMID:
29459985
11.

Parkinson disease with and without Dementia: A prevalence study and future projections.

Savica R, Grossardt BR, Rocca WA, Bower JH.

Mov Disord. 2018 Apr;33(4):537-543. doi: 10.1002/mds.27277. Epub 2018 Jan 22.

PMID:
29356127
12.

Hyperglycemic chorea/ballism ascertained over 15 years at a referral medical center.

Ryan C, Ahlskog JE, Savica R.

Parkinsonism Relat Disord. 2018 Mar;48:97-100. doi: 10.1016/j.parkreldis.2017.12.032. Epub 2017 Dec 29.

PMID:
29305082
13.

Prevalence of and indications for antipsychotic use in Parkinson's disease.

Bower JH, Grossardt BR, Rocca WA, Savica R.

Mov Disord. 2018 Feb;33(2):325-328. doi: 10.1002/mds.27256. Epub 2017 Dec 26.

PMID:
29278275
14.

Longitudinal Association Between Brain Amyloid-Beta and Gait in the Mayo Clinic Study of Aging.

Wennberg AMV, Lesnick TG, Schwarz CG, Savica R, Hagen CE, Roberts RO, Knopman DS, Hollman JH, Vemuri P, Jack CR Jr, Petersen RC, Mielke MM.

J Gerontol A Biol Sci Med Sci. 2018 Aug 10;73(9):1244-1250. doi: 10.1093/gerona/glx240.

PMID:
29236984
15.

Overall Survival and Causes of Death in Neurodegeneration-An Overlooked and Underreported Theme-Reply.

Savica R, Mielke MM.

JAMA Neurol. 2017 Nov 1;74(11):1379-1380. doi: 10.1001/jamaneurol.2017.2877. No abstract available.

PMID:
29052692
16.

Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis.

Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, Liguori R, Logroscino G.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):358-366. doi: 10.1136/jnnp-2017-316844. Epub 2017 Oct 13.

PMID:
29030419
17.

Plasma Sphingolipids are Associated With Gait Parameters in the Mayo Clinic Study of Aging.

Wennberg AMV, Schafer MJ, LeBrasseur NK, Savica R, Bui HH, Hagen CE, Hollman JH, Petersen RC, Mielke MM.

J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):960-965. doi: 10.1093/gerona/glx139.

PMID:
28977376
18.

Clinicopathologic discrepancies in a population-based incidence study of parkinsonism in olmsted county: 1991-2010.

Turcano P, Mielke MM, Josephs KA, Bower JH, Parisi JE, Boeve BF, Savica R.

Mov Disord. 2017 Oct;32(10):1439-1446. doi: 10.1002/mds.27125. Epub 2017 Aug 26.

19.

Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.

Mielke MM, Hagen CE, Wennberg AMV, Airey DC, Savica R, Knopman DS, Machulda MM, Roberts RO, Jack CR Jr, Petersen RC, Dage JL.

JAMA Neurol. 2017 Sep 1;74(9):1073-1080. doi: 10.1001/jamaneurol.2017.1359.

20.

Response to Letter by Friedman on "Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study".

Rocca WA, Savica R, Grossardt BR.

Mov Disord. 2017 Jul;32(7):1111-1112. doi: 10.1002/mds.27051. Epub 2017 Jun 14. No abstract available.

21.

Exposure to Surgery and Anesthesia After Concussion Due to Mild Traumatic Brain Injury.

Abcejo AS, Savica R, Lanier WL, Pasternak JJ.

Mayo Clin Proc. 2017 Jul;92(7):1042-1052. doi: 10.1016/j.mayocp.2017.03.012. Epub 2017 Jun 7.

PMID:
28601422
22.

Environmental Neurologic Injuries.

Savica R.

Continuum (Minneap Minn). 2017 Jun;23(3, Neurology of Systemic Disease):862-871. doi: 10.1212/CON.0000000000000470.

PMID:
28570332
23.

MR Elastography Demonstrates Unique Regional Brain Stiffness Patterns in Dementias.

ElSheikh M, Arani A, Perry A, Boeve BF, Meyer FB, Savica R, Ehman RL, Huston J 3rd.

AJR Am J Roentgenol. 2017 Aug;209(2):403-408. doi: 10.2214/AJR.16.17455. Epub 2017 Jun 1.

24.

Cleomedes of Astypalaea: A possible early sufferer of chronic traumatic encephalopathy.

Savica R, Vaz Carneiro Filho MR, Boes CJ.

J Clin Neurosci. 2017 Aug;42:193-195. doi: 10.1016/j.jocn.2017.04.040. Epub 2017 May 13.

PMID:
28511970
25.

Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Boeve BF, Graff-Radford J, Rocca WA, Mielke MM.

JAMA Neurol. 2017 Jul 1;74(7):839-846. doi: 10.1001/jamaneurol.2017.0603.

26.

Association between Various Brain Pathologies and Gait Disturbance.

Wennberg AM, Savica R, Mielke MM.

Dement Geriatr Cogn Disord. 2017;43(3-4):128-143. doi: 10.1159/000456541. Epub 2017 Feb 3. Review.

27.

Duration and Pathologic Correlates of Lewy Body Disease.

Graff-Radford J, Aakre J, Savica R, Boeve B, Kremers WK, Ferman TJ, Jones DT, Kantarci K, Knopman DS, Dickson DW, Kukull WA, Petersen RC.

JAMA Neurol. 2017 Mar 1;74(3):310-315. doi: 10.1001/jamaneurol.2016.4926.

28.

High School Football and Late-Life Risk of Neurodegenerative Syndromes, 1956-1970.

Janssen PH, Mandrekar J, Mielke MM, Ahlskog JE, Boeve BF, Josephs K, Savica R.

Mayo Clin Proc. 2017 Jan;92(1):66-71. doi: 10.1016/j.mayocp.2016.09.004. Epub 2016 Dec 12.

29.

Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of Aging.

Wennberg AMV, Savica R, Hagen CE, Roberts RO, Knopman DS, Hollman JH, Vemuri P, Jack CR Jr, Petersen RC, Mielke MM.

J Am Geriatr Soc. 2017 Apr;65(4):792-799. doi: 10.1111/jgs.14670. Epub 2016 Nov 21.

30.

Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study.

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Mielke MM, Rocca WA.

Mov Disord. 2017 Feb;32(2):227-234. doi: 10.1002/mds.26839. Epub 2016 Oct 25.

31.

Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update.

Rizzo G, Zanigni S, De Blasi R, Grasso D, Martino D, Savica R, Logroscino G.

Parkinsons Dis. 2016;2016:2983638. Epub 2016 Sep 28. Review.

32.

Trends in the Incidence of Parkinson Disease-Reply.

Rocca WA, Savica R, Grossardt BR.

JAMA Neurol. 2016 Dec 1;73(12):1498-1499. doi: 10.1001/jamaneurol.2016.3847. No abstract available.

PMID:
27749957
33.

Comparison of Gait Parameters for Predicting Cognitive Decline: The Mayo Clinic Study of Aging.

Savica R, Wennberg AM, Hagen C, Edwards K, Roberts RO, Hollman JH, Knopman DS, Boeve BF, Machulda MM, Petersen RC, Mielke MM.

J Alzheimers Dis. 2017;55(2):559-567.

34.

Epidemiology of alpha-synucleinopathies: from Parkinson disease to dementia with Lewy bodies.

Savica R, Boeve BF, Logroscino G.

Handb Clin Neurol. 2016;138:153-8. doi: 10.1016/B978-0-12-802973-2.00009-4. Review.

PMID:
27637957
35.

The clinical spectrum and natural history of pure akinesia with gait freezing.

Owens E, Josephs KA, Savica R, Hassan A, Klassen B, Bower J, Maraganore D, Matsumoto J, Ahlskog JE.

J Neurol. 2016 Dec;263(12):2419-2423. Epub 2016 Sep 13.

PMID:
27624121
36.

LRRK2 variation and dementia with Lewy bodies.

Heckman MG, Soto-Ortolaza AI, Contreras MYS, Murray ME, Pedraza O, Diehl NN, Walton R, Labbé C, Lorenzo-Betancor O, Uitti RJ, van Gerpen J, Ertekin-Taner N, Smith GE, Kantarci K, Savica R, Jones DT, Graff-Radford J, Knopman DS, Lowe VJ, Jack CR Jr, Petersen RC, Parisi JE, Rademakers R, Wszolek ZK, Graff-Radford NR, Ferman TJ, Dickson DW, Boeve BF, Ross OA.

Parkinsonism Relat Disord. 2016 Oct;31:98-103. doi: 10.1016/j.parkreldis.2016.07.015. Epub 2016 Jul 29.

37.

RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies.

Hodges K, Brewer SS, Labbé C, Soto-Ortolaza AI, Walton RL, Strongosky AJ, Uitti RJ, van Gerpen JA, Ertekin-Taner N, Kantarci K, Lowe VJ, Parisi JE, Savica R, Graff-Radford J, Jones DT, Knopman DS, Petersen RC, Murray ME, Graff-Radford NR, Ferman TJ, Dickson DW, Wszolek ZK, Boeve BF, Ross OA, Lorenzo-Betancor O.

Neurobiol Aging. 2016 Sep;45:107-108. doi: 10.1016/j.neurobiolaging.2016.03.021. Epub 2016 Mar 24.

38.

TREM2 p.R47H substitution is not associated with dementia with Lewy bodies.

Walton RL, Soto-Ortolaza AI, Murray ME, Lorenzo-Betancor O, Ogaki K, Heckman MG, Rayaprolu S, Rademakers R, Ertekin-Taner N, Uitti RJ, van Gerpen JA, Wszolek ZK, Smith GE, Kantarci K, Lowe VJ, Parisi JE, Jones DT, Savica R, Graff-Radford J, Knopman DS, Petersen RC, Graff-Radford NR, Ferman TJ, Dickson DW, Boeve BF, Ross OA, Labbé C.

Neurol Genet. 2016 Jul 14;2(4):e85. doi: 10.1212/NXG.0000000000000085. eCollection 2016 Aug.

39.

Time Trends in the Incidence of Parkinson Disease.

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA.

JAMA Neurol. 2016 Aug 1;73(8):981-9. doi: 10.1001/jamaneurol.2016.0947.

40.

MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.

Labbé C, Heckman MG, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Murray ME, Allen M, Uitti RJ, Wszolek ZK, Smith GE, Kantarci K, Knopman DS, Lowe VJ, Jack CR Jr, Ertekin-Taner N, Hassan A, Savica R, Petersen RC, Parisi JE, Maraganore DM, Graff-Radford NR, Ferman TJ, Boeve BF, Dickson DW, Ross OA.

Alzheimers Dement. 2016 Dec;12(12):1297-1304. doi: 10.1016/j.jalz.2016.05.002. Epub 2016 Jun 7. Review.

41.

Plasma sphingolipid changes with autopsy-confirmed Lewy Body or Alzheimer's pathology.

Savica R, Murray ME, Persson XM, Kantarci K, Parisi JE, Dickson DW, Petersen RC, Ferman TJ, Boeve BF, Mielke MM.

Alzheimers Dement (Amst). 2016;3:43-50.

42.

Familial aggregation of Parkinson disease in Utah: A population-based analysis using death certificates.

Savica R, Cannon-Albright LA, Pulst S.

Neurol Genet. 2016 Mar 22;2(2):e65. doi: 10.1212/NXG.0000000000000065. eCollection 2016 Apr.

43.

Tourette syndrome deep brain stimulation: a review and updated recommendations.

Schrock LE, Mink JW, Woods DW, Porta M, Servello D, Visser-Vandewalle V, Silburn PA, Foltynie T, Walker HC, Shahed-Jimenez J, Savica R, Klassen BT, Machado AG, Foote KD, Zhang JG, Hu W, Ackermans L, Temel Y, Mari Z, Changizi BK, Lozano A, Auyeung M, Kaido T, Agid Y, Welter ML, Khandhar SM, Mogilner AY, Pourfar MH, Walter BL, Juncos JL, Gross RE, Kuhn J, Leckman JF, Neimat JA, Okun MS; Tourette Syndrome Association International Deep Brain Stimulation (DBS) Database and Registry Study Group.

Mov Disord. 2015 Apr;30(4):448-71. doi: 10.1002/mds.26094. Epub 2014 Dec 5. Review.

PMID:
25476818
44.

A population-based study of the association between bullous pemphigoid and neurologic disorders.

Brick KE, Weaver CH, Savica R, Lohse CM, Pittelkow MR, Boeve BF, Gibson LE, Camilleri MJ, Wieland CN.

J Am Acad Dermatol. 2014 Dec;71(6):1191-7. doi: 10.1016/j.jaad.2014.07.052. Epub 2014 Aug 29.

45.

Dopamine receptor signaling in the forebrain: recent insights and clinical implications.

Savica R, Benarroch EE.

Neurology. 2014 Aug 19;83(8):758-67. doi: 10.1212/WNL.0000000000000719. Epub 2014 Jul 18. Review. No abstract available.

PMID:
25037203
46.

Head trauma and neurodegeneration in veterans: an additional piece of the puzzle.

Savica R.

Neurology. 2014 Jul 22;83(4):298-9. doi: 10.1212/WNL.0000000000000630. Epub 2014 Jun 25. No abstract available.

PMID:
24966404
47.

Head trauma and in vivo measures of amyloid and neurodegeneration in a population-based study.

Mielke MM, Savica R, Wiste HJ, Weigand SD, Vemuri P, Knopman DS, Lowe VJ, Roberts RO, Machulda MM, Geda YE, Petersen RC, Jack CR Jr.

Neurology. 2014 Jan 7;82(1):70-6. doi: 10.1212/01.wnl.0000438229.56094.54. Epub 2013 Dec 26.

48.

Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.

Mielke MM, Maetzler W, Haughey NJ, Bandaru VV, Savica R, Deuschle C, Gasser T, Hauser AK, Gräber-Sultan S, Schleicher E, Berg D, Liepelt-Scarfone I.

PLoS One. 2013 Sep 18;8(9):e73094. doi: 10.1371/journal.pone.0073094. eCollection 2013.

49.

Incidence of dementia with Lewy bodies and Parkinson disease dementia.

Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA.

JAMA Neurol. 2013 Nov;70(11):1396-402. doi: 10.1001/jamaneurol.2013.3579.

50.

Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications.

Chen H, Burton EA, Ross GW, Huang X, Savica R, Abbott RD, Ascherio A, Caviness JN, Gao X, Gray KA, Hong JS, Kamel F, Jennings D, Kirshner A, Lawler C, Liu R, Miller GW, Nussbaum R, Peddada SD, Rick AC, Ritz B, Siderowf AD, Tanner CM, Tröster AI, Zhang J.

Environ Health Perspect. 2013 Nov-Dec;121(11-12):1245-52. doi: 10.1289/ehp.1306967. Epub 2013 Aug 9. Review.

Supplemental Content

Loading ...
Support Center